Antigenic/JJ
specificities/NNS
of/IN
human/JJ
CD4+/JJ
T-cell/NN
clones/NNS
recovered/VBD
from/IN
recurrent/JJ
genital/JJ
herpes/NN
simplex/JJ
virus/NN
type/NN
2/CD
lesions/NNS
./.

Lesions/NNS
resulting/VBG
from/IN
recurrent/JJ
genital/JJ
herpes/NN
simplex/JJ
virus/NN
(/(
HSV/NN
)/)
infection/NN
are/VBP
characterized/VBN
by/IN
infiltration/NN
of/IN
CD4+/JJ
lymphocytes/NNS
./.
=====
We/PRP
have/VBP
investigated/VBN
the/DT
antigenic/JJ
specificity/NN
of/IN
47/CD
HSV-specific/JJ
CD4+/JJ
T-cell/NN
clones/NNS
recovered/VBN
from/IN
the/DT
HSV-2/NN
buttock/NN
and/CC
thigh/NN
lesions/NNS
of/IN
five/CD
patients/NNS
./.
=====
Clones/NNS
with/IN
proliferative/JJ
responses/NNS
to/TO
recombinant/JJ
truncated/VBN
glycoprotein/NN
B/NN
(/(
gB/NN
)/)
or/CC
gD/NN
of/IN
HSV-2/NN
or/CC
purified/VBN
natural/JJ
gC/NN
of/IN
HSV-2/NN
comprised/VBD
a/DT
minority/NN
of/IN
the/DT
total/JJ
number/NN
of/IN
HSV-specific/JJ
clones/NNS
isolated/VBN
from/IN
lesions/NNS
./.
=====
The/DT
gC2-/NN
and/CC
gD2-specific/JJ
CD4+/JJ
clones/NNS
had/VBD
cytotoxic/JJ
activity/NN
./.
=====
The/DT
approximate/JJ
locations/NNS
of/IN
the/DT
HSV-2/NN
genes/NNS
encoding/VBG
HSV-2/NN
type-specific/JJ
CD4+/JJ
antigens/NNS
have/VBP
been/VBN
determined/VBN
by/IN
using/VBG
HSV-1/NN
x/NN
HSV-2/NN
intertypic/JJ
recombinant/JJ
virus/NN
and/CC
include/VBP
the/DT
approximate/JJ
map/NN
regions/NNS
0.30/CD
to/TO
0.46/CD
,/,
0.59/CD
to/TO
0.67/CD
,/,
0.67/CD
to/TO
0.73/CD
,/,
and/CC
0.82/CD
to/TO
1.0/CD
units/NNS
./.
=====
The/DT
antigenic/JJ
specificity/NN
of/IN
an/DT
HLA/NN
DQ2-restricted/JJ
,/,
HSV-2/NN
type-specific/JJ
T-cell/NN
clone/NN
was/VBD
mapped/VBN
to/TO
amino/NN
acids/NNS
425/CD
to/TO
444/CD
of/IN
VP16/NN
of/IN
HSV-2/NN
by/IN
sequential/JJ
use/NN
of/IN
an/DT
intertypic/JJ
recombinant/JJ
virus/NN
containing/VBG
VP16/NN
of/IN
HSV-2/NN
in/IN
an/DT
HSV-1/NN
background/NN
,/,
recombinant/JJ
VP16/NN
fusion/NN
proteins/NNS
,/,
and/CC
synthetic/JJ
peptides/NNS
./.
=====
Each/DT
of/IN
the/DT
remaining/VBG
four/CD
patients/NNS
also/RB
yielded/VBD
at/IN
least/JJS
one/CD
type-specific/JJ
T-cell/NN
clone/NN
reactive/JJ
with/IN
an/DT
HSV-2/NN
epitope/NN
mapping/VBG
to/TO
approximately/RB
0.67/CD
to/TO
0.73/CD
map/NN
units/NNS
./.
=====
The/DT
antigenic/JJ
specificities/NNS
of/IN
lesion-derived/JJ
CD4+/JJ
T-cell/NN
clones/NNS
are/VBP
quite/RB
diverse/JJ
and/CC
include/VBP
at/IN
least/JJS
10/CD
epitopes/NNS
./.
=====
Human/JJ
T-cell/NN
clones/NNS
reactive/JJ
with/IN
gC/NN
and/CC
VP16/NN
are/VBP
reported/VBN
here/RB
for/IN
the/DT
first/JJ
time/NN
./.